Similarities and differences in the neuronal death processes activated by 3OH-kynurenine and quinolinic acid

被引:86
作者
Chiarugi, A [1 ]
Meli, E [1 ]
Moroni, F [1 ]
机构
[1] Univ Florence, Dipartimento Farmacol Preclin & Clin, I-50139 Florence, Italy
关键词
apoptosis; excitotoxicity; NMDA; poly-(ADP-ribose)-polymerase; tryptophan metabolism;
D O I
10.1046/j.1471-4159.2001.00335.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
3OH-Kynurenine and quinolinic acid are tryptophan metabolites able to cause, at relatively elevated concentrations, neuronal death in vitro and in vivo. In primary cultures of mixed cortical cells, the minimal concentration of these compounds leading to a significant degree of;neurotoxicity decreased from 100 to 1 muM, when the exposure time was prolonged from 24 to 72 h. NMDA receptor antagonists and inhibitors of nitric oxide synthase or poly(ADP-ribose) polymerase reduced quinolinic acid, but not 3OH-kynurenine toxicity. In contrast, scavengers of free radicals, caspase inhibitors and cyclosporin preferentially reduced 3OH-kynurenine neurotoxicity. These observations suggest that quinolinic acid causes necrosis, whereas 3OH-kynurenine-exposed neurons primarily die in apoptosis, In line with this possibility, we found that ATP levels decreased more rapidly in quinolinate- than in 3OH-kynurenine-exposed cultures and that poly(ADP-ribose) polymer, the product of poly(ADP-ribose) polymerase activity, was more abundant in the nuclei of quinolinic acid than in those of 3OH-kynurenine-exposed neurons. Because minor changes in the physiological concentrations of 3OH-kynurenine and quinolinic acid may cause neuronal death, our data suggest that these metabolites play a key role in the pathogenesis of several neurological decisions.
引用
收藏
页码:1310 / 1318
页数:9
相关论文
共 51 条
[1]  
AbdelHamid KM, 1997, J NEUROSCI, V17, P3538
[2]   GLUTAMATE-INDUCED NEURONAL DEATH - A SUCCESSION OF NECROSIS OR APOPTOSIS DEPENDING ON MITOCHONDRIAL-FUNCTION [J].
ANKARCRONA, M ;
DYPBUKT, JM ;
BONFOCO, E ;
ZHIVOTOVSKY, B ;
ORRENIUS, S ;
LIPTON, SA ;
NICOTERA, P .
NEURON, 1995, 15 (04) :961-973
[3]   REPLICATION OF THE NEUROCHEMICAL CHARACTERISTICS OF HUNTINGTONS-DISEASE BY QUINOLINIC ACID [J].
BEAL, MF ;
KOWALL, NW ;
ELLISON, DW ;
MAZUREK, MF ;
SWARTZ, KJ ;
MARTIN, JB .
NATURE, 1986, 321 (6066) :168-171
[4]   Oxidative stress as a mechanism for quinolinic acid-induced hippocampal damage: protection by melatonin and deprenyl [J].
Behan, WMH ;
McDonald, M ;
Darlington, LG ;
Stone, TW .
BRITISH JOURNAL OF PHARMACOLOGY, 1999, 128 (08) :1754-1760
[5]   Mitochondria and cell death - Mechanistic aspects and methodological issues [J].
Bernardi, P ;
Scorrano, L ;
Colonna, R ;
Petronilli, V ;
Di Lisa, F .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1999, 264 (03) :687-701
[6]   Quinolinic acid accumulation in injured spinal cord: Time course, distribution, and species differences between rat and guinea pig [J].
Blight, AR ;
Leroy, EC ;
Heyes, MP .
JOURNAL OF NEUROTRAUMA, 1997, 14 (02) :89-98
[7]  
CERESOLIBORRONI G, 1998, SOC NEUR ABSTR, V24
[8]   Kynurenine 3-mono-oxygenase activity and neurotoxic kynurenine metabolites increase in the spinal cord of rats with experimental allergic encephalomyelitis [J].
Chiarugi, A ;
Cozzi, A ;
Ballerini, C ;
Massacesi, L ;
Moroni, F .
NEUROSCIENCE, 2001, 102 (03) :687-695
[9]  
Chiarugi A, 2000, J LEUKOCYTE BIOL, V68, P260
[10]   THE ROLE OF HYDROGEN-PEROXIDE IN THE INVITRO CYTOTOXICITY OF 3-HYDROXYKYNURENINE [J].
EASTMAN, CL ;
GUILARTE, TR .
NEUROCHEMICAL RESEARCH, 1990, 15 (11) :1101-1107